AnuMed International LLC – Trademark Portfolio

Entity Type: 16

AnuMed International LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include STEVIA INTL. The owner is based in Tempe, AZ.

Ste 219

2123 S Priest Dr.

Tempe, AZ 85282

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AnuMed International LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does AnuMed International LLC have?

AnuMed International LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.

What trademark classes does AnuMed International LLC file in?

AnuMed International LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AnuMed International LLC's most well-known trademarks?

AnuMed International LLC's registered trademark portfolio includes well-known marks such as STEVIA INTL. These are among 1 currently registered trademark in the portfolio.

What is AnuMed International LLC's trademark registration success rate?

AnuMed International LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.